The stabilization and encapsulation of human growth hormone into biodegradable microspheres

Pharmaceutical Research

Volumn 14, Issue 6, 1997, Pages 730-735

  Johnson, OluFunmi L ^a   Jaworowicz, Warren ^a   Cleland, Jeffrey L ^b   Bailey, Leonie ^a   Charnis, Margarita ^a   Duenas, Eileen ^b   Wu, Chichih ^a   Shepard, Douglas ^a   Magil, Sheila ^a   Last, Thomas ^a   Jones, Andrew J S ^b   Putney, Scott D ^a  

^a ALKERMES INC   (United States)

^b GENENTECH INC   (United States)

Author keywords

Human growth hormone; Microencapsulation; Microspheres; PLGA; Poly (lactide co glycolide); Sustained release

Indexed keywords

HUMAN GROWTH HORMONE; MICROSPHERE; POLYGLACTIN; ZINC;

ANIMAL EXPERIMENT; ARTICLE; COMPLEX FORMATION; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG RELEASE; MALE; MICROENCAPSULATION; NONHUMAN; PRIORITY JOURNAL; RAT; RHESUS MONKEY; SUBCUTANEOUS DRUG ADMINISTRATION; SUSTAINED RELEASE PREPARATION;

ADMINISTRATION, CUTANEOUS; ANIMALS; CAPSULES; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, ION EXCHANGE; DRUG COMPOUNDING; DRUG STABILITY; HUMAN GROWTH HORMONE; LACTIC ACID; MACACA MULATTA; MALE; POLYGLYCOLIC ACID; POLYMERS; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS;

EID: 8544246437     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012142204132     Document Type: Article

References (32)

1. R. Langer. Science 249:1527-1533 (1990).
2. H. V. Maulding. J. Controlled Release 6:167-176 (1987).
3. K. L. Smith, M. E. Schimpf, and K. E. Thompson. Advanced Drug Delivery Reviews 4:343-357 (1990).
4. S. J. Holland, B. J. Tighe, and P. L. Gould. J. Controlled Release 4:155-180 (1986).
5. D. H. Lewis. In M. Chasin, and R. Langer, Eds, in Biodegredable Polymers as Drug Delivery Systems Marcel Dekker, New York, 1990 pp. 1-41.
6. D. R. Cowsar, T. R. Tice, R. M. Gilley, and J. P. English. Methods in Enzymology 112:101-116 (1985).
7. L. M. Sanders, B. A. Kell, G. I. McRae, and G. W. Whitehead. J. Pharm. Sci. 75:356-360 (1986).
8. Y. Ogawa, M. Yamamoto, H. Okada, T. Yashiki, and T. Shimamoto. Chem. Pharm. Bull. 5:1095-1103 (1988).
9. Y. Ogawa, H. Okada, M. Yamamota, and T. Shimamoto. Chem. Pharm. Bull. 36:2576-2581 (1988).
10. P. E. Austin, K. A. Dunn, K. Elly-Cofield, C. K. Brown, W. A. Wooden, and J. F. Bradfield. Ann. Emerg. Med. 25:328-330 (1995).
11. H. Pihlajamaki, O. Bostman, E. Hirvensalo, P. Tormala, and P. Rokkanen. J. Bone Joint Surg. 74:853-857 (1992).
12. G. Winde, B. Reers, H. Nottberg, T. Berns, J. Meyer, and H. Bunte. Eur. J. Surg. 159:301-305 (1993).
13. R. Pearlman, T. A. Bewley. In Y. J. Wang, and R. Pearlman, Eds, in Stability and Characterization of Protein and Peptide Drugs: Case Histories Plenum Press, New York, 1993 pp. 1-58.
14. W. H. Daughaday and S. Harvey. In S. Harvey, C. G. Scanes, and W. H. Daughaday, Eds, in Growth Hormone CRC Press, Boca Raton, 1995 pp. 475-504.
15. J. O. Jorgensen, N. Moller, T. Lauritzen, and J. S. Christiansen. J. Clin. Endocrinol. Metab. 70:1616-1623 (1990).
16. T. Laursen, J. O. Jorgensen, and J. S. Christiansen. Endocrinol. Metab. 1:33-40 (1994).
17. T. Laursen, O. L. Jorgensen, G. Jakobsen, B. L. Hansen, and J. S. Christiansen. J. Clin. Endocrinol. and Metab. 80:2410-2418 (1995).
18. H. Tauber, H. De Bouet du Portal, B. Sallerin-Caute, P. Rochiccioli, and R. Bastide. J. Clin. Endocrinol. and Metab. 76:1135-1139 (1993).
19. W. Gombotz, M. Healy, L. Brown. U.S. Patent 5019400 (1991).
20. G. Teshima, J. T. Stults, V. Ling, and E. Canova-Davis. J. Biol. Chem. 266:13544-13547 (1991).
21. G. Teshima and E. Canova-Davis. J. of Chromatog. 625:207-215 (1992).
22. J. E. Battersby, W. S. Hancock, E. Canova-Davis, J. Oeswein, and B. O'Connor. Int. J. Peptide Protein Res. 44:215-222 (1994).
23. J. E. Battersby, V. R. Mukku, R. G. Clark, and W. S. Hancock. Anal. Chem. 67:447-455 (1995).
24. E. Canova-Davis, I. P. Baldonado, J. A. Moore, C. G. Rudman, W. F. Bennett, and W. S. Hancock. Int. J. Peptide Protein Res. 35:17-24 (1990).
25. E. C. Roswall, V. R. Mukku, A. B. Chen, E. H. Hoff, H. Chu, P. A. McKay, K. C. Olson, J. E. Battersby, R. L. Gehant, A. Meunier, and R. L. Garnick. Biologicals 24:25-39 (1996).
26. O. Thorlacius-Ussing. Neuroendocrinology 45:233-242 (1987).
27. B. C. Cunningham, M. G. Mulkerrin, and J. A. Wells. Science 253:545-548 (1991).
28. S. P. Schwendeman, M. Cardamone, M. R. Brandon, A. Klibanov, and R. Langer. In S. Cohen, H. Bernstein, Eds, in Microspheresl Microparticles-Characterization and Pharmaceutical Application Marcel Dekker Inc., New York, 1996 pp. 1-49.
29. S. Cohen, T. Yoshioka, M. Lucarelii, L. H. Hwang, and R. Langer. Pharm. Research 8:713-720 (1991).
30. S. S. Shah, Y. Cha, and C. G. Pitt. J. Controlled Release 18:261-270 (1992).
31. O. L. Johnson, J. L. Cleland, H. J. Lee, M. Charnis, E. Duenas, W. Jaworowicz, D. Shepard, A. Shahzamani, A. J. S. Jones, and S. D. Putney. Nature Medicine 2:795-799 (1996).
32. J. L. Cleland, M. F. Powell, A. Lim, L. Barron, P. W. Berman, D. J. Eastman, J. H. Nunberg, T. Wrin, and J. C. Vennari. AIDS and Human Retroviruses 10:S21-S25 (1994).